Why Post-Thaw Viability Matters

A cell that was alive before it was frozen isn't necessarily alive after it's thawed. Here's why that distinction changes what a provider is actually administering.

The Gap Between Two Numbers

Every cryopreserved cell product has, in principle, two viability numbers: one measured before it was frozen, and one measured after it was thawed. In practice, only one of those numbers describes what ends up in a syringe.

Freezing a living cell is not a neutral, reversible pause. Ice crystal formation inside and around the cell, osmotic shifts as water moves across the membrane during cooling, and the cryoprotectant chemistry itself all place stress on the cell's membrane and organelles. Some fraction of cells that were healthy going into the freezer do not survive the trip out of it.

A pre-freeze viability figure — sometimes called a "before" number — measures a population of cells that, by the time of administration, has already been altered by cryopreservation, cold-chain transport, and thaw. It is a real measurement, but it is not a measurement of the product the patient receives.

What Actually Drives Post-Thaw Loss

• Freeze rate — uncontrolled freezing increases intracellular ice formation, which is directly damaging to membranes.
• Cryoprotectant formulation — the compound and concentration used to limit ice damage affects both protection and, at high concentrations, its own toxicity to the cell.
• Cold-chain stability — temperature excursions during storage or overnight shipment can degrade viability before the vial ever reaches the clinic.
• Thaw technique and timing — how quickly and how a product is thawed, and how long it sits before administration, both affect the final count.

Because each of these variables can differ lot to lot — even under an identical written protocol — post-thaw viability is properly treated as a per-lot result, not a fixed specification that applies uniformly to every unit a supplier has ever produced.

What This Means for a Provider

When evaluating a cellular product, the relevant question isn't "what's your viability?" as a general marketing claim. It's narrower and more useful: "What was the post-thaw viable cell count for the specific lot I'm receiving, and how was it measured?"

A supplier who can answer that with a lot-specific document is describing the product in the vial. A supplier who answers with a general spec sheet, a sterility result, or a percentage with no lot number attached is describing something else.

This page is educational reference material for licensed healthcare providers and does not constitute medical, legal, or regulatory advice. HCT/P products are not FDA-approved.